marijuana stock news

Tauriga Sciences, Inc. (TAUG)

 

Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014
Total Revenue 29   11   –   –  
Cost of Revenue 9 3
Gross Profit 20   8   –   –  
Operating Expenses
Research Development
Selling General and Administrative 717 1,054 1,793 1,681
Non Recurring 1,356
Others 30 30 30 63
Total Operating Expenses
Operating Income or Loss (728) (1,535) (1,365) (3,101)
Income from Continuing Operations
Total Other Income/Expenses Net (600) (712) 343 (1,845)
Earnings Before Interest And Taxes (1,327) (1,788) (1,480) (4,946)
Interest Expense 58 31 95 276
Income Before Tax (1,385) (1,820) (1,576) (5,221)
Income Tax Expense
Minority Interest
Net Income From Continuing Ops (1,385) (1,820) (1,576) (5,221)
Non-recurring Events
Discontinued Operations
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income (1,385) (1,820) (1,576) (5,221)
Preferred Stock And Other Adjustments
Net Income Applicable To Common Shares (1,385) (1,820) (1,576) (5,221)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

American Premium Water Corporation (HIPH) Announces Launch of New Website for LALPINA CBD Beverage

American Premium Water Corp. (HIPH) Announces Launch of New Website for LALPINA…

$CANN Requests Support From Its Shareholders

Advanced Cannabis Solutions, Inc. Requests Support From Its Shareholders to Vote at…

Next Green Wave’s (OTC: NXGWF) (CSE: NGW) Strategy To Be A Cannabis Consumer Products Goods Leader In California

Next Green Wave’s Vision to be Number 1 in Cannabis Consumer Product…

$PMCB Awaits Pivotal U.S. Study Results Expected to Lead to Human Clinical Trials

PharmaCyte Biotech Awaits Pivotal U.S. Study Results Expected to Lead to Human…